Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Melanoma 50Carcinoma, Non-Small-Cell Lung 39Carcinoma, Renal Cell 28Carcinoma, Hepatocellular 18Neoplasm Metastasis 16Neoplasms 15Colorectal Neoplasms 15Stomach Neoplasms 13Lung Neoplasms 13Adenocarcinoma Of Esophagus 11Squamous Cell Carcinoma of Head and Neck 10Carcinoma, Transitional Cell 8Brain Neoplasms 8Hodgkin Disease 7Skin Neoplasms 6Sarcoma 6Esophageal Neoplasms 6Clear-cell metastatic renal cell carcinoma 6Triple Negative Breast Neoplasms 5Prostatic Neoplasms 5Pancreatic Neoplasms 5Kidney Neoplasms 5Carcinoma, Merkel Cell 5Uveal Melanoma 4Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Recurrence 4Neuroendocrine Tumors 4Nasopharyngeal Carcinoma 4Mesothelioma 4

Interventions

Gemcitabine 5Cisplatin 5toripalimab 3Radiotherapy, Intensity-Modulated 3Nivolumab 2spartalizumab 1pembrolizumab 1camrelizumab 1Radiotherapy 1Radiation 1Phantoms, Imaging 1Patient Reported Outcome Measures 1Observation 1Magnetic Resonance Spectroscopy 1Interferon beta-1a 1Induction Chemotherapy 1Immunotherapy 1Immunohistochemistry 1Fluorouracil 1Endoscopy 1Carboplatin 1Blood Specimen Collection 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Nasopharyngeal Neoplasms × Nivolumab × Clear all
NCT04875611 2025-04-24

NIVONASO-21

Maria Sklodowska-Curie National Research Institute of Oncology

Phase 2 Recruiting
32 enrolled
Head & Neck

Nasopharyngeal Neoplasms

NCT06019130 2024-05-16

NPC-Nivo

German Society for Pediatric Oncology and Hematology GPOH gGmbH

Phase 2 Recruiting
57 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡